These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 34740880)

  • 1. COVID-19 vaccine given to children with comorbidities in England, December 2020-June 2021.
    Aiano F; Campbell C; Saliba V; Ramsay ME; Ladhani SN
    Arch Dis Child; 2022 Mar; 107(3):e16. PubMed ID: 34740880
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.
    Frieman M; Harris AD; Herati RS; Krammer F; Mantovani A; Rescigno M; Sajadi MM; Simon V
    EBioMedicine; 2021 Jun; 68():103401. PubMed ID: 34051441
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Karafillakis E; Van Damme P; Hendrickx G; Larson HJ
    Lancet; 2022 Feb; 399(10326):699-701. PubMed ID: 35123665
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 vaccines for children in LMICs: another equity issue.
    Kampmann B; Okomo U
    Lancet; 2021 Aug; 398(10302):731-732. PubMed ID: 34339625
    [No Abstract]   [Full Text] [Related]  

  • 5. Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Tuite AR; Zhu L; Fisman DN; Salomon JA
    Ann Intern Med; 2021 Apr; 174(4):570-572. PubMed ID: 33395334
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards a European strategy to address the COVID-19 pandemic.
    Priesemann V; Balling R; Bauer S; Beutels P; Valdez AC; Cuschieri S; Czypionka T; Dumpis U; Glaab E; Grill E; Hotulainen P; Iftekhar EN; Krutzinna J; Lionis C; Machado H; Martins C; McKee M; Pavlakis GN; Perc M; Petelos E; Pickersgill M; Prainsack B; Rocklöv J; Schernhammer E; Szczurek E; Tsiodras S; Van Gucht S; Willeit P
    Lancet; 2021 Sep; 398(10303):838-839. PubMed ID: 34384539
    [No Abstract]   [Full Text] [Related]  

  • 7. Missing again: US racial and ethnic data for COVID-19 vaccination.
    Krieger N; Waterman PD; Chen JT; Testa C; Hanage WP
    Lancet; 2021 Apr; 397(10281):1259-1260. PubMed ID: 33743218
    [No Abstract]   [Full Text] [Related]  

  • 8. The French health pass holds lessons for mandatory COVID-19 vaccination.
    Ward JK; Gauna F; Gagneux-Brunon A; Botelho-Nevers E; Cracowski JL; Khouri C; Launay O; Verger P; Peretti-Watel P
    Nat Med; 2022 Feb; 28(2):232-235. PubMed ID: 35022575
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    Chen JM; Sun YX; Chen JW
    J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategy and challenges for consolidating successful containment of covid-19 with population immunity in China.
    An Z; Wang F; Pan A; Yin Z; Rodewald L; Feng Z
    BMJ; 2021 Dec; 375():e066125. PubMed ID: 34853010
    [No Abstract]   [Full Text] [Related]  

  • 12. Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Amit S; Regev-Yochay G; Afek A; Kreiss Y; Leshem E
    Lancet; 2021 Mar; 397(10277):875-877. PubMed ID: 33610193
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Barnabas RV; Wald A
    Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key steps in our journey to a COVID-19 vaccine program.
    Blyth CC; Flanagan KL; Gibbs RA; Crawford NW; Cheng AC
    Med J Aust; 2021 Apr; 214(6):249-251.e1. PubMed ID: 33745153
    [No Abstract]   [Full Text] [Related]  

  • 17. To curb COVID-19, global health must go local.
    Nat Med; 2021 Jun; 27(6):929. PubMed ID: 34031608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venezuela is collapsing without COVID-19 vaccines.
    Loyo ESL; González MJ; Esparza J
    Lancet; 2021 May; 397(10287):1806. PubMed ID: 33992140
    [No Abstract]   [Full Text] [Related]  

  • 19. The long road ahead for COVID-19 vaccination in Africa.
    Jerving S
    Lancet; 2021 Sep; 398(10303):827-828. PubMed ID: 34481563
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 - Inequities, the third wave and vaccination.
    Govender I
    S Afr Fam Pract (2004); 2021 Aug; 63(1):e1-e2. PubMed ID: 34476960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.